Product image of Nideolo (Dimethyl Fumarate) supplied by GNH India

Nideolo

Active Ingredient:
Dimethyl Fumarate
Origin:
EU

Nideolo (Dimethyl Fumarate)

Dimethyl Fumarate, the active ingredient in Nideolo, is an Immunomodulator presented as an oral formulation for oral use. It is used to treat multiple sclerosis and psoriasis in adult patients.

GNH India supplies Nideolo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Pharmathen

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Dimethyl Fumarate acts on immune pathways that are central to inflammatory demyelinating and skin disorders.

  • Multiple sclerosis: reduces relapse frequency and slows disease progression.
  • Relapsing‑remitting multiple sclerosis: decreases inflammatory activity in the central nervous system.
  • Psoriasis: improves skin lesions and reduces disease severity.

How It Works

  • Dimethyl Fumarate activates the nuclear factor erythroid‑2‑related factor 2 (Nrf2) pathway, leading to increased expression of antioxidant and cytoprotective genes. This results in reduced oxidative stress and modulation of inflammatory cytokine production, thereby exerting immunomodulatory and anti‑inflammatory effects in target tissues.

Side Effects

Dimethyl Fumarate is associated with a range of adverse reactions that vary in frequency and severity.

Common Side Effects

  • Flushing: transient reddening of the skin, often on the face or neck.
  • Gastrointestinal discomfort: nausea, abdominal pain, or diarrhea.
  • Lymphopenia: mild reduction in peripheral lymphocyte count.
  • Headache: mild to moderate intensity.
  • Upper respiratory tract infection: common cold‑like symptoms.

Serious or Rare Side Effects

  • Severe lymphopenia: marked decrease in lymphocytes increasing infection risk.
  • Progressive multifocal leukoencephalopathy (PML): rare opportunistic brain infection.
  • Hepatic injury: elevated liver enzymes or hepatitis.
  • Severe allergic reactions: rash, angioedema, or anaphylaxis.
  • Acute pancreatitis: abdominal pain with elevated enzymes.

Precautions & Warnings

When prescribing Dimethyl Fumarate, clinicians should consider several safety measures.

  • Monitor lymphocyte counts: check baseline and periodic CBC to detect lymphopenia.
  • Assess liver function: perform baseline and periodic liver enzyme tests.
  • Avoid in active infection: defer treatment until infection resolves.
  • Use caution in renal impairment: adjust monitoring as needed.
  • Pregnancy and breastfeeding: safety unknown; discuss risks with the prescriber.
  • Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Dimethyl Fumarate may interact with other medicines, requiring attention to potential additive effects.

Major Interactions (Avoid)

  • Immunosuppressants: combined use may increase infection risk.
  • Live vaccines: administration while on therapy can lead to uncontrolled infection.
  • Antiepileptic drugs (e.g., carbamazepine): may reduce Dimethyl Fumarate efficacy.

Moderate Interactions (Monitor Closely)

  • Antacids: may affect gastrointestinal absorption.
  • Statins: monitor liver enzymes for additive hepatotoxicity.
  • Alcohol: can exacerbate flushing and gastrointestinal irritation.

Frequently Asked Questions

Nideolo contains dimethyl fumarate and is prescribed for adults with multiple sclerosis, particularly the relapsing‑remitting form, and for patients with moderate to severe plaque psoriasis. In both conditions the drug helps reduce disease activity by modulating immune responses.

Dimethyl fumarate activates the Nrf2 cellular pathway, which increases antioxidant defenses and suppresses pro‑inflammatory cytokine production. This dual action protects nerve cells in multiple sclerosis and reduces skin inflammation in psoriasis, leading to clinical improvement.

The exact dosage of Nideolo is determined by the prescribing clinician based on the patient’s condition, disease severity, and individual response. Healthcare professionals follow approved dosing guidelines and may adjust the regimen during treatment.

Safety data for dimethyl fumarate in pregnancy and lactation are limited. The product is classified as having an unknown risk, so clinicians weigh potential benefits against possible risks and discuss options with the patient before initiating therapy.

To request Nideolo, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Dimethyl fumarate is an oral immunomodulator, offering a convenient alternative to injectable or infusion therapies. Compared with interferon‑beta, it has a similar efficacy in reducing relapse rates but a distinct safety profile, with flushing and lymphopenia being more common, while injection‑site reactions are avoided.

Nideolo should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight and excessive heat to maintain stability and potency throughout its shelf life.

Nideolo is taken orally, usually with food to lessen gastrointestinal discomfort. The tablets are swallowed whole with a glass of water and should be taken at the same time each day as directed by the prescriber.

The most serious risks include severe lymphopenia, which can predispose to opportunistic infections such as progressive multifocal leukoencephalopathy (PML), and rare cases of hepatic injury or severe allergic reactions. Patients should be monitored regularly for these events.

Nideolo is contraindicated in patients with known hypersensitivity to dimethyl fumarate or any excipients, those with active serious infections, and individuals receiving live vaccines. Caution is also advised for patients with severe hepatic impairment or existing severe lymphopenia.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Dimethyl Fumarate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT